Cargando…
A qualitative study on the impact of caring for an ambulatory individual with nonsense mutation Duchenne muscular dystrophy
BACKGROUND: Duchenne muscular dystrophy is a rare genetic neuromuscular disorder, which can result in early death due to disease progression. Ataluren is indicated for the treatment of nonsense mutation Duchenne muscular dystrophy, in ambulatory individuals aged two years and older. This study explo...
Autores principales: | Williams, Kate, Davidson, Ian, Rance, Mark, Buesch, Katharina, Acaster, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353428/ https://www.ncbi.nlm.nih.gov/pubmed/34374872 http://dx.doi.org/10.1186/s41687-021-00344-8 |
Ejemplares similares
-
Symptoms and impacts of ambulatory nonsense mutation Duchenne muscular dystrophy: a qualitative study and the development of a patient-centred conceptual model
por: Williams, Kate, et al.
Publicado: (2021) -
Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients
por: McDonald, Craig M, et al.
Publicado: (2021) -
Symptoms and impacts of aromatic l-amino acid decarboxylase (AADC) deficiency among individuals with different levels of motor function
por: Williams, Kate, et al.
Publicado: (2022) -
Deep Learning of Ultrasound Imaging for Evaluating Ambulatory Function of Individuals with Duchenne Muscular Dystrophy
por: Liao, Ai-Ho, et al.
Publicado: (2021) -
Cost of Illness in Patients with Duchenne Muscular Dystrophy in Portugal: The COIDUCH Study
por: Labisa, Pedro, et al.
Publicado: (2021)